Toxoplasmosis in Cats: Risks During Pregnancy and One Health Implications

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. The definitive host is the domestic cat and other felids, in which the parasite completes its sexual cycle and produces oocysts [1, 2]. The life cycle involves three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [3, 1]. Cats become infected through ingestion of tissue cysts from intermediate hosts (e.g., rodents, birds) or, less commonly, through ingestion of sporulated oocysts from the environment [2, 4]. Following ingestion, bradyzoites are released in the feline small intestine, invade enterocytes, and undergo a complex developmental process culminating in sexual recombination and the production of unsporulated oocysts [3, 1]. A single cat can shed millions of oocysts in its feces for one to three weeks post-infection [5, 2]. Oocysts sporulate and become infectious within one to five days in the environment and remain viable for months to years in soil and water [6, 7]. The enteroepithelial cycle in the cat is tightly regulated, and recent single-cell transcriptomic studies have elucidated the dynamic gene expression patterns governing this sexual development [1, 8].

Epidemiology and Seroprevalence

T. gondii infection is distributed globally, with seroprevalence rates varying widely by geographic region, host species, and management practices [9, 2, 7]. In domestic cats, seroprevalence reflects prior exposure and the presence of tissue cysts. Studies have reported seroprevalence rates ranging from 20% to 60% in various populations [9, 2, 7]. For example, a study in Hong Kong found a seroprevalence of 37.5% in privately-owned cats and 45.2% in community cats [9]. In Jordan, a seroprevalence of 41.3% was reported in domestic cats [2]. High seroprevalence has also been documented in wild felids, indicating widespread environmental contamination [10]. Risk factors for feline infection include outdoor access, hunting behavior, raw meat consumption, and age [9, 2, 4]. In urban informal settlements, environmental degradation and social marginalization are associated with higher exposure risks for both animals and humans [6, 7]. The presence of free-roaming cat populations and poor sanitation infrastructure contribute to sustained oocyst contamination in these settings [6, 5].

Clinical Signs and Pathology in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic [2, 11]. Clinical disease is more common in kittens, immunocompromised cats, or those co-infected with other pathogens. The most frequently reported clinical signs are non-specific and include fever, lethargy, anorexia, and lymphadenopathy [12, 11]. Ocular toxoplasmosis can present as uveitis, chorioretinitis, or anterior chamber inflammation [12]. Neurological signs, such as ataxia, seizures, and behavioral changes, may occur due to encephalitis or meningoencephalitis [13]. Pulmonary toxoplasmosis, though less common, can cause dyspnea and interstitial pneumonia. Pathologically, the hallmark lesions are necrotic foci in the liver, lungs, pancreas, and central nervous system, often associated with tachyzoite proliferation [12, 14]. Tissue cysts containing bradyzoites are most commonly found in the brain, skeletal muscle, and myocardium [14]. The parasite can also be detected in reproductive tissues, raising questions about vertical transmission in cats [14].

Pathogenesis and Host-Parasite Interactions

After oral infection, bradyzoites convert to tachyzoites, which disseminate via the lymphatics and bloodstream to infect a wide range of nucleated cells [3, 1]. Tachyzoites actively invade host cells through a gliding motility mechanism and the formation of a parasitophorous vacuole, which protects them from host lysosomal degradation [3]. The host immune response, particularly cell-mediated immunity involving interferon-gamma and cytotoxic T lymphocytes, is critical for controlling tachyzoite proliferation and inducing bradyzoite differentiation [15, 8]. In the feline intestine, the parasite undergoes a unique sexual cycle that is not observed in intermediate hosts [1]. The molecular mechanisms governing this switch from asexual to sexual development are under active investigation, with recent studies identifying key transcription factors and microRNA expression patterns that regulate this process [3, 1, 8]. The ability of T. gondii to alter host behavior in rodents, and potentially in other species, is a well-documented phenomenon that may enhance transmission to the definitive feline host [13].

Diagnostics

Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods. Serological detection of anti-T. gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies is the most common approach [16, 17, 12]. Commercial enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays are widely used [16, 17]. The detection of IgM antibodies suggests recent infection or reactivation, while IgG indicates past exposure [12]. Rapid point-of-care tests, such as colloidal gold immunochromatographic strips targeting the SAG1 antigen, have been developed for use in multiple host species, including cats [16, 17]. These strips offer a practical alternative for field-based screening [16, 17]. Molecular detection of T. gondii DNA by polymerase chain reaction (PCR) is highly sensitive and specific [5, 18]. PCR can be performed on fecal samples to detect oocyst shedding, on blood or tissue biopsies to detect active infection, and on cerebrospinal fluid in cases of neurological disease [5, 18]. An antisense PCR assay has been developed to improve detection sensitivity in domestic cats [18]. The MIC17A antigen has shown potential as a marker for both entero-epithelial and chronic stage infection in cats [12]. Histopathological examination of tissues with immunohistochemistry can confirm the presence of tachyzoites or tissue cysts [19, 14].

flowchart TD
    A[Clinical suspicion of feline toxoplasmosis], > B{Serological testing}
    B, > C[IgG and IgM ELISA / Immunochromatographic strip]
    C, > D{IgM positive?}
    D, >|Yes| E[Recent or active infection]
    D, >|No| F{IgG positive?}
    F, >|Yes| G[Past exposure / chronic infection]
    F, >|No| H[No evidence of infection]
    E, > I[Confirm with PCR on blood or feces]
    G, > J[Consider PCR if clinical signs persist]
    I, > K[Positive PCR confirms active infection]
    J, > L[Positive PCR may indicate reactivation]
    K, > M[Initiate antiprotozoal therapy if indicated]
    L, > M

Treatment and Control

Treatment of clinical toxoplasmosis in cats typically involves a combination of clindamycin, pyrimethamine, and sulfonamides, although clindamycin is the most commonly used drug [15, 20]. Treatment is aimed at controlling tachyzoite proliferation; it does not eliminate tissue cysts. Supportive care, including fluid therapy and nutritional support, is important in severe cases. Prevention of infection in cats is primarily achieved by restricting outdoor access, preventing hunting, and feeding only cooked or commercially processed food [20, 7]. Litter boxes should be cleaned daily to prevent oocyst sporulation, and pregnant women or immunocompromised individuals should avoid handling cat litter [20]. Vaccination against toxoplasmosis in cats is not currently available in most regions, but significant research is underway using gene-edited live-attenuated strains and mRNA-based platforms [21, 15]. These vaccines aim to reduce oocyst shedding and prevent tissue cyst formation, thereby breaking the transmission cycle [21, 15].

Risks During Pregnancy: The Cat Toxoplasmosis Baby Connection

The primary zoonotic concern regarding feline toxoplasmosis is the risk of primary maternal infection during pregnancy, which can lead to congenital transmission and severe fetal outcomes [22, 23, 20]. This risk is the central focus of the search term "cat toxoplasmosis baby". Pregnant women who are seronegative for T. gondii are susceptible to primary infection if they ingest sporulated oocysts from contaminated soil, water, or unwashed produce, or if they handle cat litter containing oocysts [23, 20]. The risk of congenital transmission is highest when maternal infection occurs during the second or third trimester, although the severity of fetal disease is greatest with first-trimester infections [22, 20]. Congenital toxoplasmosis can result in miscarriage, stillbirth, or a range of neonatal abnormalities including hydrocephalus, intracranial calcifications, chorioretinitis, and developmental delays [22, 20]. Studies have investigated seroprevalence and risk factors in women with a history of abortion or stillbirth, finding significant associations with T. gondii seropositivity [22]. The risk is not limited to direct cat contact; environmental contamination with oocysts from cat feces is a major source of human infection [6, 20]. Pregnant women are advised to avoid cleaning litter boxes, wear gloves when gardening, wash fruits and vegetables thoroughly, and practice rigorous hand hygiene [23, 20]. Veterinary professionals and students are also at increased occupational risk and should adhere to strict biosafety protocols [24].

One Health Implications

Toxoplasmosis is a quintessential One Health issue, linking the health of cats, wildlife, livestock, humans, and the environment [15, 25, 7]. Cats serve as the definitive host and are the primary source of environmental oocyst contamination [1, 2]. Oocysts are highly resistant and can be transported via water runoff, wind, and mechanical vectors, contaminating pastures, gardens, and water sources [6, 7]. This environmental contamination poses a risk to livestock, particularly sheep and goats, in which T. gondii is a major cause of abortion and stillbirth [25, 19, 26, 27]. Seroprevalence in goats and sheep can exceed 50% in some regions, leading to significant economic losses and potential foodborne transmission through undercooked meat [25, 19, 27]. In cattle, seroprevalence is generally lower but still poses a risk [26]. Wildlife species, including wild felids, European bison, and other herbivores, serve as sentinels for environmental contamination and can maintain the parasite in sylvatic cycles [10, 28]. The parasite has been detected in aborted equine and caprine fetuses, confirming its role in reproductive failure across multiple species [29, 19]. The development of effective vaccines for cats and livestock is a critical One Health priority to reduce oocyst shedding and tissue cyst formation in food animals [21, 15]. Surveillance programs that integrate serological and molecular testing across domestic and wild animal populations are essential for understanding transmission dynamics and implementing targeted control measures [25, 7, 28]. Public health education, particularly for pregnant women and immunocompromised individuals, remains a cornerstone of prevention [23, 30, 20]. The high seroprevalence observed in veterinary professionals underscores the need for occupational health programs [24]. Furthermore, the parasite's ability to infect a wide range of hosts, including those with sickle cell disease and transplant recipients, highlights the importance of considering toxoplasmosis in differential diagnoses for immunocompromised patients [31, 32]. The role of the AB blood group system in feline susceptibility has been investigated, but no significant association was found [11].

Conclusion

Toxoplasma gondii infection in cats represents a complex interplay of parasite biology, host immunity, and environmental factors with profound implications for animal and human health. The risk of congenital toxoplasmosis following primary maternal infection, often colloquially referred to as "cat toxoplasmosis baby", remains a significant public health concern. A One Health approach that integrates veterinary surveillance, environmental management, vaccine development, and public education is essential for reducing the burden of this zoonotic parasite. Continued research into the molecular mechanisms of sexual development, improved diagnostic tools, and effective vaccines will be critical for future control efforts.

References

[1] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026.

[2] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026.

[3] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026.

[4] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026.

[5] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026.

[6] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026.

[7] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025.

[8] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026.

[9] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026.

[10] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025.

[11] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025.

[12] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026.

[13] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026.

[14] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026.

[15] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026.

[16] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026.

[17] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026.

[18] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026.

[19] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026.

[20] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026.

[21] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026.

[22] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026.

[23] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026.

[24] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026.

[25] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026.

[26] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026.

[27] Villa-Mancera A, Vargas-Tizatl E, Robles-Robles JM, et al. High Seroprevalence of Toxoplasma gondii and Neospora caninum Infections Among Goats in Mexico Is Associated with Climatic, Environmental, and Risk Factors. Pathogens. 2025. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[28] Kołodziej-Sobocińska M, Holec-Gąsior L, Ferra B, et al. A long-term serological survey of Toxoplasma gondii in European bison (Bison bonasus) - the largest european herbivore. Vet Res Commun. 2025.

[29] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026.

[30] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026.

[31] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026.

[32] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026.

[33] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026.

[34] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026.

[35] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026.